SQUAMOUS CELL CARCINOMA
Clinical trials for SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer combo trial halted early
Disease control TerminatedThis study tested a new drug called OC-001, either by itself or combined with avelumab (an immunotherapy), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The trial was stopped early, and only 73 people were e…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
Experimental combo for advanced head and neck cancer shows early safety signals
Disease control TerminatedThis early-phase study tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiotherapy is safe for people with stage IV head and neck cancer. Only 3 participants were enrolled before the study was stopped. The main goal was to find the highest safe dose a…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Scientists hunt for genetic signs that predict lung Cancer's next move
Knowledge-focused TerminatedThis study aimed to find genetic changes in lung tissue and blood that could help predict how squamous cell lung cancer progresses. Researchers planned to collect samples from 200 people having a lung procedure. The study was stopped early and enrolled only 22 participants, so re…
Matched conditions: SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 12:04 UTC